James Wilbur, Chief Commercial Officer at 10x Genomics, Inc. (TXG), sold 6,928 shares at $43.34 ($300K) on 2023-11-22, disclosed to the SEC on 2023-11-27.
Open-market sale of $300k TXG by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.34 | 3,464 | $150K | 50.0% |
| 2 | $43.34 | 3,464 | $150K | 50.0% |
| Total | $43.34 avg | 6,928 | $300K | 100% |
| Filing → |
| TXG | SELL | 2023-05-25 | $17K | — | Filing → |